We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+1.86%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$54.7B
AUM Growth
+$1.45B
Cap. Flow
+$1.02B
Cap. Flow %
1.86%
Top 10 Hldgs %
17.33%
Holding
3,009
New
39
Increased
2,170
Reduced
725
Closed
55

Top Buys

Rank Stock Value
1
FIS icon
Fidelity National Information Services
FIS
+$65.3M
2
GPN icon
Global Payments
GPN
+$40.3M
3
MSFT icon
Microsoft
MSFT
+$37.9M
4
LHX icon
L3Harris
LHX
+$32.8M
5
AMZN icon
Amazon
AMZN
+$32.5M

Sector Composition

Rank Sector Weight
1 Technology 18.64%
2 Financials 15.56%
3 Healthcare 12.85%
4 Consumer Discretionary 10.31%
5 Industrials 10.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AEO icon
876
American Eagle Outfitters
AEO
$3.03B
$8.38M 0.02%
516,488
+17,579
+4% +$293K
KMT icon
877
Kennametal
KMT
$2.75B
$8.36M 0.02%
272,087
+4,323
+2% +$138K
NVT icon
878
nVent Electric
NVT
$26.3B
$8.36M 0.02%
379,470
-8,697
-2% -$195K
MOG.A icon
879
Moog Inc Class A
MOG.A
$12.9B
$8.35M 0.02%
102,948
+3,444
+3% +$293K
REXR icon
880
Rexford Industrial Realty
REXR
$8.25B
$8.33M 0.02%
189,317
+18,638
+11% +$797K
LEA icon
881
Lear
LEA
$6.21B
$8.33M 0.02%
70,670
+1,515
+2% +$184K
CCK icon
882
Crown Holdings
CCK
$13.2B
$8.29M 0.02%
125,557
-1,418
-1% -$90.8K
LEG icon
883
Leggett & Platt
LEG
$1.43B
$8.29M 0.02%
202,555
+2,021
+1% +$79.3K
ALNY icon
884
Alnylam Pharmaceuticals
ALNY
$29.3B
$8.29M 0.02%
103,046
-9
-0% -$712
RL icon
885
Ralph Lauren
RL
$22.5B
$8.28M 0.02%
86,682
+1,359
+2% +$134K
CDP icon
886
COPT Defense Properties
CDP
$4.29B
$8.27M 0.02%
277,790
+376
+0.1% +$10.6K
JHG
887
DELISTED
Janus Henderson
JHG
$8.27M 0.02%
368,240
-10,961
-3% -$228K
IONS icon
888
Ionis Pharmaceuticals
IONS
$9.15B
$8.26M 0.02%
137,861
-822
-0.6% -$53.6K
EVR icon
889
Evercore
EVR
$12.4B
$8.25M 0.02%
102,979
-4,181
-4% -$346K
JAZZ icon
890
Jazz Pharmaceuticals
JAZZ
$16.4B
$8.21M 0.02%
64,068
+17
+0% +$2.28K
MNRO icon
891
Monro
MNRO
$410M
$8.2M 0.02%
103,828
+2,051
+2% +$164K
GT icon
892
Goodyear
GT
$2.07B
$8.2M 0.02%
569,407
-5,940
-1% -$79.1K
BFH icon
893
Bread Financial
BFH
$4.54B
$8.17M 0.01%
79,909
-2,130
-3% -$240K
PRLB icon
894
Protolabs
PRLB
$2.11B
$8.17M 0.01%
80,021
+1,382
+2% +$141K
AKR icon
895
Acadia Realty Trust
AKR
$2.97B
$8.15M 0.01%
285,235
+21,587
+8% +$601K
PWR icon
896
Quanta Services
PWR
$104B
$8.13M 0.01%
215,155
+1,441
+0.7% +$52K
AVNT icon
897
Avient
AVNT
$3.5B
$8.12M 0.01%
248,578
-6,464
-3% -$205K
RDN icon
898
Radian Group
RDN
$5.27B
$8.11M 0.01%
355,199
+14,006
+4% +$323K
WWW icon
899
Wolverine World Wide
WWW
$1.59B
$8.11M 0.01%
286,794
+1,021
+0.4% +$27.4K
OZK icon
900
Bank OZK
OZK
$5.7B
$8.08M 0.01%
296,426
-2,145
-0.7% -$59.6K

Similar funds

RhumbLine Advisers's Q3 2019 Portfolio in Review

As of Q3 2019, RhumbLine Advisers held 3,009 positions worth $54.7B, up 2.7% from $53.3B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Trading was light in Q3 2019: portfolio turnover was 3.1%. RhumbLine Advisers opened 39 new positions and exited 55, leaving the 3,009-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.

  • RhumbLine Advisers's largest Q3 2019 buy was Avantor: 187,780 shares worth $2.76M.
  • RhumbLine Advisers added most to Fidelity National Information Services in Q3 2019, an estimated $65.3M increase.
  • RhumbLine Advisers's biggest Q3 2019 reduction was Leidos, cutting an estimated $15M.
  • RhumbLine Advisers fully exited Anadarko Petroleum in Q3 2019, selling an estimated $64.3M.
  • RhumbLine Advisers's ten largest holdings make up 17% of its $54.7B portfolio in Q3 2019.
  • RhumbLine Advisers opened 39 new positions and closed 55 in Q3 2019.
  • RhumbLine Advisers's portfolio value rose 2.7% quarter-over-quarter to $54.7B.

Based on RhumbLine Advisers's 13F filing for Q3 2019, filed 23 Oct 2019.